SCHEMBL26435274

SCHEMBL26435274

c1ccc2c(-c3ccc(-c4nc(-c5cccc6ccc7ccccc7c56)nc(-c5cccc6oc7ccccc7c56)n4)cc3)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ENPP3 O14638 1/20 0.40
ENPP1 P22413 1/20 0.40
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 5/20 0.40
HSD17B10 Q99714 5/20 0.40
MAPT P10636 4/20 0.40
HPGD P15428 4/20 0.40
MAPK1 P28482 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ATM Q13315 2/20 0.40
TP53 P04637 2/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
RAB9A P51151 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24306440 0.96 TDP1 (0.42) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL26048243 0.94 TDP1 (0.42) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL25504717 0.94 ENPP1 (0.39) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL24990918 0.94 TDP1 (0.43) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL23820656 0.93 ENPP1 (0.43) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL24307039 0.92 MAPT (0.41) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL26435259 0.92 MAPT (0.43) TDP1L3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL23821398 0.92 MAPT (0.48) TDP1L3MBTL1ENPP3ENPP1KDM4E
SCHEMBL26435252 0.92 MAPT (0.44) TDP1L3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL24991530 0.91 TDP1 (0.42) TDP1L3MBTL1ENPP3ENPP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 TDP1 1017/4885L3MBTL1 1536/4885ENPP3 1062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.